Celecoxib prodrugs possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Synthesis, biological evaluation and nitric oxide release studies
Authors:
- Khaled R.A. AbdellatifKAKhaled R.A. Abdellatif
- Morshed A. ChowdhuryMCMorshed A. Chowdhury
- Carlos A. VelázquezCVCarlos A. Velázquez
- Zhangjian HuangZHZhangjian Huang
- Ying DongYDYing Dong
- Dipankar DasDDDipankar Das
- Gang YuGYGang Yu
- Mavanur R. SureshMSMavanur R. Suresh
- Edward E. KnausEKEdward E. Knaus
- 1 August 2010
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (15) , 4544-4549
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research (CIHR) (MOP-14712)
This publication has 26 references indexed in Scilit:
- Selective PGHS-2 inhibitors: a rational approach for treatment of the inflammation.Current Medicinal Chemistry, 2002
- Selective cyclooxygenase-2 (COX-2) inhibitors and potential risk of cardiovascular eventsBiochemical Pharmacology, 2002
- Cyclooxygenase-2—10 Years LaterThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Cyclooxygenase-2: A Therapeutic TargetAnnual Review of Medicine, 2002
- The Disputed Role of COX-2 in Myocardial Infarction, Is the Jury Still Out?Journal of Molecular and Cellular Cardiology, 2002
- Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- 4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, Valdecoxib: A Potent and Selective Inhibitor of COX-2Journal of Medicinal Chemistry, 2000
- The discovery of rofecoxib, [MK 966, VIOXX®, 4-(4′-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitorBioorganic & Medicinal Chemistry Letters, 1999
- Synthesis and Biological Evaluation of the 1,5-Diarylpyrazole Class of Cyclooxygenase-2 Inhibitors: Identification of 4-[5-(4-Methylphenyl)-3- (trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, Celecoxib)Journal of Medicinal Chemistry, 1997